LOOK AT THIS IF YOU'RE INTERESTED IN:
Learning about Georgia’s experience transitioning away from Gavi support to full domestic financing of its national immunization program.
HOW YOU CAN USE THIS MATERIAL:
Policymakers, immunization practitioners, and other country stakeholders can use this case study to understand some of the complex challenges that may arise during the Gavi transition process and adapt potential solutions based on lessons learned from Georgia’s experience.
OVERVIEW:
Georgia graduated from Gavi support in 2018, and since then, their National Immunization Program (NIP) has been fully financed from domestic sources. Georgia’s NIP has remained a strong performing program in the EURO region with an historically well-maintained cold chain network and monitoring and surveillance system, as well as high coverage rates for most vaccines. This country case study highlights some of the key lessons learned from Georgia’s transition, including enabling factors, as well potential risks, to its future programmatic and financial sustainability.